ALK-ABELLO A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 2.8K
- Market Cap
- -
- Website
- http://www.alk.net
Clinical Trials
6
Active:5
Completed:1
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
53
CANADA:16
CIMA_AEMPS:9
NMPA:5
+2 more agencies
Drug Approvals
Mites allergens ALK（503）D.p
- Product Name
- 安脱达
- Approval Number
- 国药准字SJ20140015
- Approval Date
- Sep 11, 2024
NMPA
Mites allergens ALK（503）D.p
- Product Name
- 安脱达
- Approval Number
- 国药准字SJ20140016
- Approval Date
- Sep 11, 2024
NMPA
Mites Allergens Prick Solution
- Product Name
- 安刺
- Approval Number
- 国药准字SJ20150031
- Approval Date
- Jul 16, 2020
NMPA
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)No trials found
News
No news found